IP Library Granted Patent US 8,288,322
Granted Patent B2
US 8,288,322 · App. 10/045,674 · Granted Oct 16, 2012

Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,322
App. No.
10/045,674
Granted
Oct 16, 2012
Kind
B2
Abstract

A library containing a collection of genetic packages that display a member of a diverse family of peptides, polypeptides or proteins and that collectively display at least a portion of the family, the displayed peptides, polypeptides or proteins being encoded by DNA sequences containing sequences encoding a heavy chain CDR region is described.

Claims (22)

1. A library comprising a collection of members of a family, the family comprising a diversity of antibodies or functional fragments thereof, wherein the antibodies or functional fragments thereof each comprise a VH CDR1, a VH CDR2, a VH CDR3 and framework regions and the antibodies or functional fragments are encoded by DNA sequences comprising sequences encoding

(a) the VH CDR1, wherein the VH CDR1 comprises the amino acid sequence according to the formula -X 1 -Y-X 2 -M-X 3 - (SEQ ID NO:636), wherein X 1 , X 2 , and X 3 are independently selected from the group consisting of A, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, and Y,

(b) the VH CDR2, wherein the VH CDR2 comprises the amino acid sequence according to the formula X 4 -I-X 5 -X 6 -S-G-G-X 7 -T-X 8 -Y-A-D-S-V-K-G- (SEQ ID NO:637), wherein X 4 and X 5 are independently selected from the group consisting of Y, R, W, V, G, and S, X 6 is selected from the group consisting of P and S, and X 7 and X 8 are independently selected from the group consisting of A, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, and Y,

(c) the VH CDR3, wherein the sequence encoding the VH CDR3 is from the CDR3 region of an immunoglobulin gene of a B cell, and

(d) the framework regions, wherein the framework regions comprises VH 3-23 framework regions or VH3-23 related germline framework regions.

2. The library according to claim 1 , wherein the antibodies or functional fragments thereof further comprise an immunoglobulin light chain, and said DNA sequences further comprise a sequence encoding the immunoglobin light chain.

3. The library according to claim 2 , wherein said sequence encoding an immunoglobin light chain is from a B cell.

4. The library according to claim 3 , wherein said B cell is from a blood sample from an autoimmune patient.

5. The library according to claim 4 , wherein the autoimmune patient is diagnosed with a disorder selected from the group consisting of systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, antiphospholipid syndrome and vasculitis.

6. The library according to claim 1 , wherein said antibodies or functional fragments thereof are linked via a short linker to the final portion of M13 gene III.

7. The library according to claim 1 , wherein the diversity of antibodies or functional fragments thereof is displayed on genetic packages.

8. The library according to claim 7 , wherein said genetic packages are M13 phage.

9. The library according to claim 8 , wherein said DNA sequences are in a phage vector.

10. The library according to claim 9 , wherein said phage vector comprises a wild-type gene iii and a truncated gene iii for display of the antibody or functional fragment thereof.

11. The library according to claim 8 , wherein said DNA sequences are in a phagemid vector.

12. The library according to claim 8 , wherein said displayed antibodies or functional fragments thereof are linked via a short linker to the final portion of M13 gene III.

13. The library according to claim 2 , wherein the diversity of antibodies or functional fragments thereof is displayed on genetic packages.

14. The library according to claim 13 , wherein said genetic packages are M13 phage.

15. The library according to claim 14 , wherein said DNA sequences are in a phage vector.

16. The library according to claim 14 , wherein said DNA sequences are in a phagemid vector.

17. The library according to claim 14 , wherein said displayed antibodies or functional fragments thereof are linked via a short linker to the final portion of M13 gene III.

18. The library of claim 1 , wherein the functional fragments are Fab fragments or scFv fragments.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2015
From: LFRP INVESTORS, L.P.
To: DYAX CORP.
Reel/Frame 036902/0703 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2012
From: HEALTHCARE ROYALTY PARTNERS, L.P. F/K/A COWEN HEALTHCARE ROYALTY PARTNERS, L.P.
To: DYAX CORP., A DELAWARE CORPORATION
Reel/Frame 028827/0906 →
SECURITY AGREEMENT Recorded Aug 22, 2012
From: DYAX CORP., A DELAWARE CORPORATION
To: LFRP INVESTORS, L.P., A DELAWARE LIMITED PARTNERSHIP
Reel/Frame 028828/0517 →